GPvP Committee
03/06/2015 15:59
Please refer to Guideline on good pharmacovigilance practices (GVP) Module VIII – Post - authorization safety studies (Rev 1) and Guideline on good pharmacovigilance practices (GVP) –Module VI – Management and reporting of adverse reactions to medicinal products.